Journal of Drug Targeting (JDT)

Journal of Drug Targeting is a subscription-based, peer-reviewed journal that publishes research on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs. Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules, as well as on the identification of novel drug targets. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, RNA-based therapeutics (e.g. mRNA, microRNAs), gene-editing and gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as small-molecule drugs, aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of therapeutic, diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

Journal of Drug Targeting (JDT) is :-

• International, Peer-Reviewed, Open Access, Refereed, small-molecule drugs, aptamers, mononucleotides, monoclonal antibodies, biological sciences, pharmacology, toxicology, chemistry , Online or Print , 10-issues-year Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1061-186X, E-ISSN: 1029-2330, Established: 1993, Impact Factor: 4.3
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE